Liver sinusoidal endothelial cells and liver regeneration

Journal of Clinical Investigation

Volumn 123, Issue 5, 2013, Pages 1861-1866

  DeLeve, Laurie D ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MARROW; CELL PROLIFERATION; ENDOTHELIUM CELL; HUMAN; LIVER INJURY; LIVER REGENERATION; LIVER SINUSOID; NONHUMAN; PRIORITY JOURNAL; REVIEW; STEM CELL;

ANIMALS; BONE MARROW CELLS; CELL PROLIFERATION; ENDOTHELIAL CELLS; HEPATOCYTE GROWTH FACTOR; HEPATOCYTES; HUMANS; LIVER; LIVER DISEASES; LIVER REGENERATION; RATS; STEM CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84877136071     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI66025     Document Type: Review

References (58)

1. Maher JJ. Cell-specific expression of hepatocyte growth factor in liver: Upregulation in sinusoidal endothelial cells after carbon tetrachloride. J Clin Invest. 1993;91(5):2244-2252.
2. Greene AK, et al. Endothelial-directed hepatic regeneration after partial hepatectomy. Ann Surg. 2003;237(4):530-535.
3. LeCouter J, et al. Angiogenesis-independent endothelial protection of liver: role of VEGFR-1. Science. 2003;299(5608):890-893.
4. Ding B-S, et al. Inductive angiocrine signals from sinusoidal endothelium are required for liver regeneration. Nature. 2010;468(7321):310-315.
5. Wang L, Wang X, Xie G, Wang L, Hill CK, DeLeve LD. Liver sinusoidal endothelial cell progenitor cells promote liver regeneration in rats. J Clin Invest. 2012;122(4):1567-1573.
6. Wisse E, De Zanger RB, Charels K, van der Smissen P, McCuskey RS. The liver sieve: considerations concerning the structure and function of endothelial fenestra, the sinusoidal wall and the space of Disse. Hepatology. 1985;5(4):683-692.
7. Barberá-Guillem E, Rocha M, Alvarez A, Vidal-Vanaclocha F. Differences in the lectin-binding patterns of the periportal and perivenous endothelial domains in the liver sinusoids. Hepatology. 1991;14(1):131-139.
8. Scoazec JY, Racine L, Couvelard A, Flejou JF, Feldmann G. Endothelial cell heterogeneity in the normal human liver acinus: in situ immuno histochemical demonstration. Liver. 1994;14(3):113-123.
9. Wack KE, Ross MA, Zegarra V, Sysko LR, Watkins SC, Stolz DB. Sinusoidal ultrastructure evaluated during the revascularization of regenerating rat liver. Hepatology. 2001;33(2):363-378.
10. Xie G, et al. Isolation of periportal, mid-lobular and centrilobular rat liver sinusoidal endothelial cells enables study of zonated drug toxicity. Am J Physiol Gastrointest Liver Physiol. 2010;299(5):G1204-G1210.
11. Elvevold K, Smedsrød B, Martinez I. The liver sinusoidal endothelial cell: a cell type of controversial and confusing identity. Am J Physiol Gastrointest Liver Physiol. 2007;294(2):391-400.
12. Smedsrød B, et al. Hepatic sinusoidal cells in health and disease: update from the 14th International Symposium. Liver Int. 2009;29(4):490-501.
13. DeLeve LD. Dacarbazine toxicity in murine liver cells: a novel model of hepatic endothelial injury and glutathione defense. J Pharmacol Exp Ther. 1994;268(3):1261-1270.
14. DeLeve LD. Cellular target of cyclophosphamide toxicity in the murine liver: role of glutathione and site of metabolic activation. Hepatology. 1996; 24(4):830-837.
15. DeLeve LD, Wang X, Kuhlenkamp JF, Kaplowitz N. Toxicity of azathioprine and monocrotaline in murine sinusoidal endothelial cells and hepatocytes: the role of glutathione and relevance to hepatic venooclusive disease. Hepatology. 1996; 23(3):589-599.
16. DeLeve LD, Wang X, Kaplowitz N, Shulman HM, Bart JA, van der Hoek A. Sinusoidal endothelial cells as a target for acetaminophen toxicity: direct action versus requirement for hepatocyte activation in different mouse strains. Biochem Pharmacol. 1997;53(9):1339-1345.
17. Ito Y, Bethea NW, Abril ER, McCuskey RS. Early hepatic microvascular injury in response to acetaminophen toxicity. Microcirculation. 2003; 10(5):391-400.
18. Walker RM, Racz WJ, McElligott TF. Scanning electron microscopic examination of acetaminophen-induced hepatotoxicity and congestion in mice. Am J Pathol. 1983;113(3):321-330.
19. Walker RM, Racz WJ, McElligott TF. Acetaminophen-induced hepatotoxic congestion in mice. Hepatology. 1985;5(2):233-240.
20. DeLeve LD, Ito I, Bethea NW, McCuskey MK, Wang X, McCuskey RS. Embolization by sinusoidal lining cell obstructs the microcirculation in rat sinusoidal obstruction syndrome. Am J Physiol Gastrointest Liver Physiol. 2003;284(6):G1045-G1052.
21. Caldwell-Kenkel C, Thurman RG, Lemasters JJ. Selective loss of nonparenchymal cell viability after cold ischemic storage of rat livers. Transplantation. 1988;45(4):834-837.
22. Caldwell-Kenkel JC, Currin RT, Tanaka Y, Thurman RG, Lemasters JJ. Reperfusion injury to endothelial cells following cold ischemic storage of rat livers. Hepatology. 1989;10(3):292-299.
23. Caldwell-Kenkel JC, Currin RT, Tanaka Y, Thurman RG, Lemasters JJ. Kupffer cell activation and endothelial cell damage after storage of rat livers: effects of reperfusion. Hepatology. 1991;13(1):83-95.
24. McKeown CMB, Edwards V, Phillips MJ, Harvey PRC, Petrunka CN, Strasberg SM. Sinusoidal lining cell damage: the critical injury in cold preservation of liver allografts in the rat. Transplantation. 1988;46(2):178-191.
25. Lopez Farre A, et al. Endothelial cells inhibit NO generation by vascular smooth muscle cells. Role of transforming growth factor-beta. Arterioscler Thromb Vasc Biol. 1996;16(10):1263-1268.
26. Powell RJ, Carruth JA, Basson MD, Bloodgood R, Sumpio BE. Matrix-specific effect of endothelial control of smooth muscle cell migration. J Vasc Surg. 1996;24(1):51-57.
27. Sato Y, et al. The mechanism for the activation of latent TGF-β during co-culture of endothelial cells and smooth muscle cells: cell-type specific targeting of latent TGF-β to smooth muscle cells. J Cell Biol. 1993;123(5):1249-1254.
28. Vernon SM, Campos MJ, Haystead T, Thompson MM, DiCorleto PE, Owens GK. Endothelial cell-conditioned medium downregulates smooth muscle contractile protein expression. Am J Physiol. 1997;272(2 pt 1):C582-C591.
29. Waybill PN, Chinchilli VM, Ballermann BJ. Smooth muscle cell proliferation in response to co-culture with venous and arterial endothelial cells. J Vasc Interv Radiol. 1997;8(3):375-381.
30. DeLeve LD, Wang X, Hu L, McCuskey MK, McCuskey RS. Rat liver sinusoidal endothelial cell phenotype is under paracrine and autocrine control. Am J Physiol Gastrointest Liver Physiol. 2004;287(4):G757-G763.
31. DeLeve LD, Wang X, Guo Y. Sinusoidal endothelial cells prevent rat stellate cell activation and promote reversion to quiescence. Hepatology. 2008; 48(3):920-930.
32. Xie G, et al. Role of liver sinusoidal endothelial cell differentiation in progression and regression of rat hepatic fibrosis. Gastroenterology. 2012; 142(4):918-927.
33. Harb R, et al. Bone marrow progenitor cells repair rat hepatic sinusoidal endothelial cells after liver injury. Gastroenterology. 2009;137(2):704-712.
34. McCloskey TW, Todaro JA, Laskin DL. Lipopolysaccharide treatment of rats alters antigen expression and oxidative metabolism in hepatic macrophages and endothelial cells. Hepatology. 1992; 16(1):191-203.
35. Wang L, et al. Hepatic vascular endothelial growth factor regulates recruitment of rat liver sinusoidal endothelial cell progenitor cells. Gastroenterology. 2012;143(6):1555-1563.
36. Kiehl MJ, Yilmaz OH, Terhorst C, Morrison SJ. SLAM family receptors distinguish stem and progenitor cells and reveal endothelial niches for stem cells. Cell. 2005;121(7):1109-1121.
37. Shimizu H, et al. Vascular endothelial growth factor secreted by replicating hepatocytes induces sinusoidal endothelial cell proliferation during regeneration after partial hepatectomy in rats. J Hepatol. 2001;34(5):683-689.
38. Taniguchi E, Sakisaka S, Matsuo K, Tanikawa K, Sata M. Expression and role of vascular endothelial growth factor in liver regeneration after partial hepatectomy in rats. J Histochem Cytochem. 2001;49(1):121-130.
39. DeLeve LD, et al. Characterization of a reproducible rat model of hepatic veno-occlusive disease. Hepatology. 1999;29(6):1779-1791.
40. Donahower B, et al. Vascular endothelial growth factor and hepatocyte regeneration in acetaminophen toxicity. Am J Physiol Gastrointest Liver Physiol. 2006;291(1):G102-G109.
41. Ishikawa K, et al. Expressions of vascular endothelial growth factor in nonparenchymal as well as parenchymal cells in rat liver after necrosis. Biochem Biophys Res Commun. 1999;254(3):587-593.
42. Mochida S, Ishikawa K, Inao M, Shibuya M, Fujiwara K. Increased expressions of vascular endothelial growth factor and its receptors, flt-1 and KDR/flk-1, in regenerating rat liver. Biochem Biophys Res Commun. 1996;226(1):176-179.
43. Papastefanou VP, et al. VEGF isoforms and receptors expression throughout acute acetaminophen-induced liver injury and regeneration. Arch Toxicol. 2007;81(10):729-741.
44. Marino G, et al. New model of liver regeneration induced through use of vascular endothelial growth factor. Transplant Proc. 2006;38(4):1193-1194.
45. Namisaki T, et al. Salvage effect of the vascular endothelial growth factor on chemically induced acute severe liver injury in rats. J Hepatol. 2006; 44(3):568-575.
46. Donahower BC, et al. Human recombinant vascular endothelial growth factor reduces necrosis and enhances hepatocyte regeneration in a mouse model of acetaminophen toxicity. J Pharmacol Exp Ther. 2010;334(1):33-43.
47. Michalopoulos GK. Liver regeneration. J Cell Physiol. 2007;213(2):286-300.
48. Michalopoulos GK. Liver regeneration after partial hepatectomy: critical analysis of mechanistic dilemmas. Am J Pathol. 2010;176(1):2-13.
49. Pediaditakis P, Lopez-Talavera JC, Petersen B, Monga SP, Michalopoulos GK. The processing and utilization of hepatocyte growth factor/scatter factor following partial hepatectomy in the rat. Hepatology. 2001;34(4 pt 1):688-693.
50. Yanagita K, Nagaike M, Ishibashi H, Niho Y, Matsumoto K, Nakamura T. Lung may have an endocrine function producing hepatocyte growth factor in response to injury of distal organs. Biochem Biophys Res Commun. 1992;182(2):802-809.
51. Kono S, Nagaike M, Matsumoto K, Nakamura T. Marked induction of hepatocyte growth factor mRNA in intact kidney and spleen in response to injury of distant organs. Biochem Biophys Res Commun. 1992;186(2):991-998.
52. Kim HJ, et al. Inhibitor of DNA binding 1 activates vascular endothelial growth factor through enhancing the stability and activity of hypoxia-inducible factor-1alpha. Mol Cancer Res. 2007;5(4):321-329.
53. Lee TK, et al. Regulation of angiogenesis by Id-1 through hypoxia-inducible factor-1alpha-mediated vascular endothelial growth factor up-regulation in hepatocellular carcinoma. Clin Cancer Res. 2006;12(23):6910- 6919.
54. Ling MT, et al. Overexpression of Id-1 in prostate cancer cells promotes angiogenesis through the activation of vascular endothelial growth factor (VEGF). Carcinogenesis. 2005;26(10):1668-1676.
55. Lyden D, et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med. 2001;7(11):1194-1201.
56. Olsen PS, Poulsen SS, Kirkegaard P. Adrenergic effects on secretion of epidermal growth factor from Brunner's glands. Gut. 1985;26(9):920-927.
57. Urbich C, et al. Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J Mol Cell Cardiol. 2005;39(5):733-742.
58. Malato Y, et al. Fate tracing of mature hepatocytes in mouse liver homeostasis and regeneration. J Clin Invest. 2011;121(12):4850-4860.